Home >
Medicine Info >
K-Nat Injection
Loading interface...

K-Nat Injection

Manufactured byKONTEST CHEMICALS LTD
ContainsMenadione
Description
K-Nat Injection is a fat-soluble vitamin precursor which is used for the prevention and control of bleeding associated with a low blood level of prothrombin or factor VII. It is also used for the treatment of patients with Vitamin K deficiency (too little vitamin K in the body).
QUICK LINKS:
Side effectsConcernsUsage

Side effects

Major & minor side effects for K-Nat Injection

  • Skin rash
  • Muscle stiffness
  • Difficulty in breathing
  • Dizziness
  • Chills
  • Chest pain
  • Nausea or vomiting
  • Abdominal pain
  • Decreased appetite
  • Headache
  • Flushing of face
  • Excessive sweating
  • Dry mouth
  • Diarrhea
  • Tiredness
  • Injection site pain

Uses of K-Nat Injection

What is it prescribed for?

  • Hypoprothrombinemia
  • Vitamin K deficiency
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The amount of time required for this medicine to show its action is not clinically established.
  • How long do the effects of this medicine last?
    The amount of time for which this medicine remains active in the body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit-forming tendencies were reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women unless absolutely necessary. Your doctor will determine the best course of treatment after assessing the condition and evaluating the risks and benefits associated with the use of this medicine.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless necessary. The risks and benefits should be discussed with the doctor before taking/receiving this medicine.

Allergy

This medicine is not recommended for use if you have a known history of allergy to menadione or vitamin K supplements.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless absolutely necessary. Your doctor will determine the best course of treatment after assessing the condition and evaluating the risks and benefits associated with the use of this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless necessary. The risks and benefits should be discussed with the doctor before taking/receiving this medicine.
General warnings

Other medicines

Report the use of all medicines including herbs and supplements to the doctor before beginning treatment with this K-Nat Injection.

Liver impairment

This medicine should be used with extreme caution in patients with liver impairment due to the increased risk of worsening of the patient's condition. Close monitoring of liver function and appropriate dose adjustments may be required in some cases based on the clinical condition.

Severe allergic reactions

Severe allergic reactions or hypersensitivity reactions, including anaphylactic shock, low blood pressure, breathing difficulties, urticaria (skin rash), etc. may occur with the use of K-Nat Injection. Appropriate corrective measures or dose adjustments may be required in some cases based on the clinical condition.

Prothrombin time

It is necessary to monitor the prothrombin time regularly in patients receiving therapy with K-Nat Injection.

Missed Dose

Injection: Since this medicine is usually administered by a qualified healthcare professional in the clinical/hospital setting, the likelihood of a missed dose is very low. Tablet: Take the missed dose as soon as you remember. If it is almost time for the next scheduled dose, then the missed dose can be skipped. Do not double the dose to make up for the missed dose.

Overdose

Injection: Since this medicine is administered in the hospital setting by a qualified healthcare professional, the likelihood of an overdose is very less. However, emergency medical treatment will be initiated by the doctor if an overdose is suspected. Tablet: Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Oral anti-coagulants medicines

Disease interactions

Hepatic and/or biliary impairment

Conditions like liver and/or biliary impairment may alter the desired effects of K-Nat Injection. Appropriate dose adjustments may be necessary for patients with these medical conditions.
Food interactions
Information not available.
Lab interactions
Information not available.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.
Injection: This medicine is usually administered in the clinical/hospital setting under the supervision of a qualified healthcare professional. Follow all the instructions given by your doctor. Inform the doctor if you have a known allergy to this medicine. Report all your current medicines as well as your medical conditions to the doctor before receiving this medicine. Tablet: Take this medicine following all directions mentioned on the label or as prescribed by the doctor. Do not take in larger or smaller quantities or for longer than recommended.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

Does not cause sleepiness

How it works
This medicine helps in the production of clotting factors that are necessary for blood to clot normally in the body.
Legal Status

Approved

Unknown

Unknown

Unknown

Classification

Category

Hemostatics, Vitamins

Schedule

Schedule H

Menadione [Internet]. Drugbank.ca. 2019 [cited 8 January 2019]. Available from:

https://www.drugbank.ca/drugs/DB00170

Menadione [Internet]. Pubchem.ncbi.nlm.nih.gov. 2019 [cited 5 September 2019]. Available from:

https://pubchem.ncbi.nlm.nih.gov/compound/Menadione
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 5 Sep 2019

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.